Allopurinol to prevent post-ERCP pancreatitis: Blind interim analysis of a randomized placebo-controlled trial

被引:1
|
作者
Romagnuolo, J
Sandha, G
Kruger, C
May, G
Cole, N
Bass, S
Lalor, E
Bain, V
McKaigney, J
Fedorak, R
机构
关键词
D O I
10.1016/S0016-5107(05)01116-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:AB195 / AB195
页数:1
相关论文
共 50 条
  • [21] A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis
    Kapetanos, Dimitrios
    Kokozidis, Georgios
    Christodoulou, Dimitrios
    Mistakidis, Konstantinos
    Sigounas, Dimitrios
    Dimakopoulos, Konstantinos
    Kitis, Georgios
    Tsianos, Epaminondas V.
    GASTROINTESTINAL ENDOSCOPY, 2007, 66 (03) : 513 - 518
  • [22] A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis
    Budzynska, A
    Marek, T
    Nowak, A
    Kaczor, R
    Nowakovska-Dulawa, E
    ENDOSCOPY, 2001, 33 (09) : 766 - 772
  • [23] Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial
    Phillip, Veit
    Pukitis, Aldis
    Epstein, Alexey
    Hapfelmeier, Alexander
    Haf, David
    Schwab, Miriam
    Demir, Ihsan Ekin
    Rosendahl, Jonas
    Hoffmeister, Albrecht
    Schmid, Roland M.
    Weber, Andreas
    Alguel, Hana
    ENDOSCOPY INTERNATIONAL OPEN, 2019, 7 (07) : E860 - E868
  • [24] IV Ibuprofen for Prevention of Post-ERCP Pancreatitis in Children: A Randomized Placebo-controlled Feasibility Study
    Troendle, David M.
    Gurram, Bhaskar
    Huang, Rong
    Barth, Bradley A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 70 (01): : 121 - 126
  • [25] Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial
    Andriulli, A
    Clemente, R
    Solmi, L
    Terruzzi, V
    Suriani, R
    Sigillito, A
    Leandro, G
    Leo, P
    De Maio, G
    Perri, F
    GASTROINTESTINAL ENDOSCOPY, 2002, 56 (04) : 488 - 495
  • [26] Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis
    Mosler, P
    Sherman, S
    Marks, J
    Watkins, JL
    Geenen, JE
    Jamidar, P
    Fogel, EL
    Lazzeu-Pannell, L
    Temkit, M
    Tarnasky, P
    Block, KP
    Frakes, JT
    Aziz, AA
    Malik, P
    Nickl, N
    Slivka, A
    Goff, J
    Lehman, GA
    GASTROINTESTINAL ENDOSCOPY, 2005, 62 (02) : 245 - 250
  • [27] Does high-dose allopurinol prevent post-ERCP pancreatitis?
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 (5): : 202 - 203
  • [28] A Randomized Controlled Trial of Rectal Indomethacin for the Prevention of Post-ERCP Pancreatitis
    Elmunzer, B. J.
    Scheiman, James M.
    Lehman, Glen A.
    Chak, Amitabh
    Mosler, Patrick
    Higgins, Peter D.
    Hayward, Rodney A.
    Romagnuolo, Joseph
    Elta, Grace H.
    Sherman, Stuart
    Fogel, Evan L.
    GASTROINTESTINAL ENDOSCOPY, 2012, 75 (04) : 161 - 161
  • [29] Effect of Rectal Indomethacin and/or Pancreatic Stents to Prevent Post-ERCP Pancreatitis: Post-Hoc Analysis of a Randomized Controlled Trial
    Levenick, John M.
    Gordon, Stuart R.
    Gardner, Timothy
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB272 - AB272
  • [30] A Randomized Trial of Rectal Indomethacin and Sublingual Nitrates to Prevent Post-ERCP Pancreatitis
    Sotoudehmanesh, Rasoul
    Eloubeidi, Mohamad Ali
    Asgari, Ali Ali
    Farsinejad, Maryam
    Khatibian, Morteza
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (06): : 903 - 909